Toll-like receptors in inflammatory bowel diseases: a decade later.

PubWeight™: 1.79‹?› | Rank: Top 3%

🔗 View Article (PMC 2958454)

Published in Inflamm Bowel Dis on September 01, 2010

Authors

Elke Cario1

Author Affiliations

1: Division of Gastroenterology & Hepatology, University Hospital of Essen, and Medical School, University of Duisburg-Essen, Essen, Germany. elke.cario@uni-due.de

Associated clinical trials:

Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease (ADcSVF-IBD) | NCT02952131

Articles citing this

Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature (2011) 6.43

Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol (2012) 1.62

Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity (2014) 1.28

Cyclic dinucleotides and the innate immune response. Cell (2013) 1.21

Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Mol Med (2013) 1.17

Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol (2014) 1.15

Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PLoS One (2013) 1.13

The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis (2014) 1.13

The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int (2015) 1.07

Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol (2011) 1.06

Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer. Gastroenterology (2011) 1.05

Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC Bioinformatics (2014) 1.00

Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort. PLoS One (2014) 1.00

MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits. Nat Commun (2014) 0.98

DNA repair is indispensable for survival after acute inflammation. J Clin Invest (2012) 0.96

Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry (2015) 0.96

Innate immune activation in intestinal homeostasis. J Innate Immun (2011) 0.94

How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res (2015) 0.94

β-Arrestin-1 deficiency protects mice from experimental colitis. Am J Pathol (2013) 0.93

IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis (2014) 0.92

Implication of intestinal VDR deficiency in inflammatory bowel disease. Biochim Biophys Acta (2012) 0.91

Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD. PLoS One (2013) 0.91

Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases. BMC Immunol (2012) 0.91

Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol (2015) 0.91

The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation. PLoS One (2013) 0.90

Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs. Stem Cells Transl Med (2013) 0.89

Evidence of inflammatory system involvement in Parkinson's disease. Biomed Res Int (2014) 0.89

Novel players in inflammatory bowel disease pathogenesis. Curr Gastroenterol Rep (2012) 0.87

The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Front Immunol (2014) 0.86

TLR signaling modulates side effects of anticancer therapy in the small intestine. J Immunol (2015) 0.86

Nutritional modulators of ulcerative colitis: clinical efficacies and mechanistic view. World J Gastroenterol (2013) 0.86

Viruses, autophagy genes, and Crohn's disease. Viruses (2011) 0.86

Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis. J Immunol (2013) 0.86

TLR9 is important for protection against intestinal damage and for intestinal repair. Sci Rep (2012) 0.85

Antibiotic-Induced Depletion of Murine Microbiota Induces Mild Inflammation and Changes in Toll-Like Receptor Patterns and Intestinal Motility. Microb Ecol (2015) 0.85

Role of the C-type lectin receptors MCL and DCIR in experimental colitis. PLoS One (2014) 0.85

Chemokine CXCL11 links microbial stimuli to intestinal inflammation. Clin Exp Immunol (2011) 0.83

Effect of ageing on colonic mucosal regeneration. World J Gastroenterol (2011) 0.83

Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma? Clin Exp Immunol (2015) 0.83

Apoptosis, Necrosis, and Necroptosis in the Gut and Intestinal Homeostasis. Mediators Inflamm (2015) 0.83

Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-κB Mediated Inflammation in Colon Cancer Patients. PLoS One (2016) 0.83

Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity. Dig Dis Sci (2012) 0.82

NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci (2014) 0.82

The noncommensal bacterium Methylococcus capsulatus (Bath) ameliorates dextran sulfate (Sodium Salt)-Induced Ulcerative Colitis by influencing mechanisms essential for maintenance of the colonic barrier function. Appl Environ Microbiol (2012) 0.82

Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel disease. Parasit Vectors (2011) 0.81

Anti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytes. Biomed Res Int (2014) 0.81

Caspase-8 controls the gut response to microbial challenges by Tnf-α-dependent and independent pathways. Gut (2014) 0.80

Microbial activation of gut dendritic cells and the control of mucosal immunity. J Interferon Cytokine Res (2013) 0.80

Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort. PLoS One (2015) 0.80

Regulation of Toll-like receptor 5 gene expression and function on mucosal dendritic cells. PLoS One (2012) 0.80

Food derived bioactive peptides and intestinal barrier function. Int J Mol Sci (2014) 0.80

Genetic deletion of dectin-1 does not affect the course of murine experimental colitis. BMC Gastroenterol (2012) 0.80

Intestinal inflammation responds to microbial tissue load independent of pathogen/non-pathogen discrimination. PLoS One (2012) 0.79

Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses. Eur J Immunol (2016) 0.79

Effect of oral administration of metronidazole or prednisolone on fecal microbiota in dogs. PLoS One (2014) 0.79

The Citrobacter rodentium mouse model: studying pathogen and host contributions to infectious colitis. J Vis Exp (2013) 0.79

Expression of Toll-like receptors in nasal epithelium in allergic rhinitis. APMIS (2015) 0.79

Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacology (2016) 0.78

Human Milk Components Modulate Toll-Like Receptor-Mediated Inflammation. Adv Nutr (2016) 0.78

Campylobacter jejuni Increases Flagellar Expression and Adhesion of Noninvasive Escherichia coli: Effects on Enterocytic Toll-Like Receptor 4 and CXCL-8 Expression. Infect Immun (2015) 0.78

Post-Transcriptional Regulation of Toll-Interacting Protein in the Intestinal Epithelium. PLoS One (2016) 0.78

Assessing DNA methylation in the developing human intestinal epithelium: potential link to inflammatory bowel disease. Mucosal Immunol (2015) 0.77

Innate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune Diseases. Front Immunol (2016) 0.77

Role of toll-like receptor 4 in colorectal carcinogenesis: a meta-analysis. PLoS One (2014) 0.77

ISG15 in Host Defense Against Candida albicans Infection in a Mouse Model of Fungal Keratitis. Invest Ophthalmol Vis Sci (2017) 0.77

Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro. World J Gastroenterol (2015) 0.76

Mucins and toll-like receptors: kith and kin in infection and cancer. Cancer Lett (2012) 0.76

Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology (2015) 0.76

Modulation of Toll-like receptor signaling in innate immunity by natural products. Int Immunopharmacol (2016) 0.76

The Immunological Basis of Inflammatory Bowel Disease. Gastroenterol Res Pract (2016) 0.75

Lipopolysaccharides: from Erinyes to Charites. Mediators Inflamm (2012) 0.75

Live Combined Bacillus subtilis and Enterococcus faecium Ameliorate Murine Experimental Colitis by Immunosuppression. Int J Inflam (2014) 0.75

Identification of genetic susceptibility loci for intestinal Behçet's disease. Sci Rep (2017) 0.75

TLR2-Dependent Signaling for IL-15 Production Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes. Mediators Inflamm (2016) 0.75

Toll-Like Receptor 4 Modulates Small Intestine Neuromuscular Function through Nitrergic and Purinergic Pathways. Front Pharmacol (2017) 0.75

Intestinal Serotonin Transporter Inhibition by Toll-Like Receptor 2 Activation. A Feedback Modulation. PLoS One (2016) 0.75

Functional analysis of pattern recognition receptors in miniature dachshunds with inflammatory colorectal polyps. J Vet Med Sci (2014) 0.75

Epigenetics and innate immunity: the 'unTolld' story. Immunol Cell Biol (2016) 0.75

IQ Motif-Containing GTPase-Activating Protein 2 (IQGAP2) Is a Novel Regulator of Colonic Inflammation in Mice. PLoS One (2015) 0.75

mRNA expression of TLR4, TLR9 and NF-κB in a neonatal murine model of necrotizing enterocolitis. Mol Med Rep (2016) 0.75

hnRNP I regulates neonatal immune adaptation and prevents colitis and colorectal cancer. PLoS Genet (2017) 0.75

Effect of EPEC endotoxin and bifidobacteria on intestinal barrier function through modulation of toll-like receptor 2 and toll-like receptor 4 expression in intestinal epithelial cell-18. World J Gastroenterol (2017) 0.75

Articles cited by this

(truncated to the top 100)

Microbial ecology: human gut microbes associated with obesity. Nature (2006) 36.98

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92

Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60

Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08

Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity (1998) 18.12

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science (2003) 17.57

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet (2006) 15.14

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74

A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest (2006) 11.89

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08

Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (2006) 9.95

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol (2004) 9.42

Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20

The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79

Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 8.68

Inflammatory bowel disease. N Engl J Med (2009) 8.62

XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell (2008) 8.43

A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A (1998) 8.40

ATP drives lamina propria T(H)17 cell differentiation. Nature (2008) 8.02

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest (1996) 7.97

Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity (1999) 7.90

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86

Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science (2007) 7.65

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med (2009) 7.53

A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 7.45

Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol (2001) 6.62

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology (2004) 6.47

IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest (2008) 6.17

Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2009) 6.10

Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med (2002) 6.00

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology (2004) 5.94

Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A (2004) 5.93

Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol (2003) 5.87

Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity (2008) 5.82

Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A (2008) 5.78

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun (2000) 5.65

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science (2007) 5.54

Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol (2002) 5.41

Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest (2004) 5.39

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science (2000) 5.38

Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity (2007) 5.36

Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol (2006) 5.35

Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05

Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A (2005) 5.05

High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol (2005) 5.04

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med (2009) 4.94

Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity (2007) 4.87

Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature (2008) 4.87

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol (2009) 4.76

Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med (2006) 4.53

Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 4.45

Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol (2005) 4.28

Toll-like receptors and innate immunity. Biochem Biophys Res Commun (2009) 4.26

Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med (2008) 4.24

Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest (2007) 4.18

Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity (2007) 4.17

Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat Immunol (2006) 4.15

Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol (2000) 4.12

Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology (2005) 4.10

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99

Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity (2006) 3.98

Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe (2007) 3.88

The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol (2007) 3.72

CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology (2003) 3.70

Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol (2001) 3.59

Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem (2002) 3.58

Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol (2001) 3.45

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest (1995) 3.43

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology (2005) 3.41

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest (2005) 3.36

Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science (1996) 3.32

Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature (2009) 3.25

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut (2004) 3.17

Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol (2006) 3.16

Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology (2004) 3.11

Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest (2008) 3.00

Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology (2007) 2.99

Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology (2003) 2.97

Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol (2007) 2.96

Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest (2008) 2.88

Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88

Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med (2008) 2.80

Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology (2002) 2.80

Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog (2010) 2.79

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology (2006) 2.78

A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A (2009) 2.77

A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol (1998) 2.74